Sandoz Debuts Denosumab Duo In Canada

Company Claims First Canadian Launch Of Biosimilar Rivals To Prolia And Xgeva

 
• By David Wallace
  
Canadian flag with syringe and vials
Two denosumab biosimilars have been launched by Sandoz in Canada • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products